First mRNA Vaccine Administered to Elephant to Combat Deadly Herpes Virus
TL;DR Summary
An Asian elephant at Houston Zoo has received the first mRNA vaccine against the deadly elephant endotheliotropic herpesvirus (EEHV), which is a leading cause of death among young Asian elephants in captivity. Developed by Dr. Paul Ling at Baylor College of Medicine, the vaccine aims to boost immunity in young elephants, similar to how Covid-19 vaccines work in humans. The trial vaccine was administered to Tess, a 40-year-old elephant, following a series of juvenile deaths in zoos worldwide. Researchers are monitoring Tess's health and plan to vaccinate more elephants if no side effects are observed.
Topics:health#asian-elephants#herpes-virus#houston-zoo#mrna-vaccine#wildlife-conservation#wildlife-health
- First Asian elephant vaccinated in fight against deadly herpes virus The Guardian
- Elephants receive first of its kind vaccine The Wildlife Society
- First mRNA EEHV Vaccine Approved; Administered to Zoo Elephant BioSpace
- Groundbreaking mRNA vaccine administered to captive elephant to fight EEHV News-Medical.Net
- Fighting EEHV in elephants: How mRNA vaccines can offer hope against viruses affecting animals Labiotech.eu
Reading Insights
Total Reads
0
Unique Readers
1
Time Saved
2 min
vs 3 min read
Condensed
82%
533 → 95 words
Want the full story? Read the original article
Read on The Guardian